Longeveron Inc.

LGVN · Nasdaq · SIC 2834: Pharmaceutical Preparations
139
SEC Filings

Business Summary

1 Item 1A. Risk Factors 25 Item 1B. Unresolved Staff Comments 71 Item 1c. Cybersecurity 71 Item 2. Properties 73 Item 3. Legal Proceedings 73 Item 4. Mine Safety Disclosures 73 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 74 Item 6. [Reserved] 74 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 75 Item 7A. Quantitative and Qualitative Disclosures about Market Risk 84 Item 8....

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionLGVNdiscussed_in_filing Cybersecurity
topic_mentionLGVNdiscussed_in_filing Cybersecurity
topic_mentionLGVNdiscussed_in_filing Cybersecurity
topic_mentionLGVNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001193125-26-110664EDGAR101K words
2025-02-282024-12-310000950170-25-029968EDGAR—
2024-02-272023-12-310001213900-24-017521EDGAR—
2023-03-142022-12-310001213900-23-020006EDGAR—
2022-03-112021-12-310001213900-22-011894EDGAR—
2021-03-302020-12-310001213900-21-018716EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-264604EDGAR27K words
2025-08-132025-06-300000950170-25-107983EDGAR—
2025-05-082025-03-310000950170-25-066889EDGAR—
2024-11-122024-09-300000950170-24-125338EDGAR—
2024-08-142024-06-300001213900-24-068987EDGAR—
2024-05-142024-03-310001213900-24-042909EDGAR—
2023-11-092023-09-300001213900-23-085194EDGAR—
2023-08-112023-06-300001213900-23-065909EDGAR—
2023-05-122023-03-310001213900-23-039003EDGAR—
2022-11-142022-09-300001213900-22-072161EDGAR—
2022-08-122022-06-300001213900-22-047372EDGAR—
2022-05-132022-03-310001213900-22-026433EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-250001213900-26-034045EDGAR1K words
2026-03-240001213900-26-033501EDGAR—
2026-03-120001213900-26-026930EDGAR—
2026-03-090001213900-26-024839EDGAR—
2026-02-130001213900-26-016519EDGAR—
2025-11-120001213900-25-108533EDGAR—
2025-11-040001213900-25-106117EDGAR—
2025-10-010001213900-25-094710EDGAR—
2025-09-260001213900-25-092316EDGAR—
2025-09-190001213900-25-089595EDGAR—

139 total filings indexed. 111 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001721484
TickerLGVN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 270176b1f641bd3690f82c899faae5562cbb07d5708c99cb00e931175e4e1ce8
parent: 294f58dac3e268fe67b8f8069703fc28289d927cefe5c40daf490661b89e9400
content hash: 61b62c5e21c1b5e4a15877babb6bfc0b948993542f78f6bfbeb51f16caa8b34b
signed: 2026-04-13T04:46:01.857Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf